Cancerous HLA class I expression and regulatory T cell infiltration in gastric cancer. (Q50960953)

26 March 2018

title

Cancerous HLA class I expression and regulatory T cell infiltration in gastric cancer. (English)

1 reference

26 March 2018

author name string

Sumiya Ishigami

1

1 reference

26 March 2018

Takaaki Arigami

2

1 reference

26 March 2018

Yoshikazu Uenosono

3

1 reference

26 March 2018

Masataka Matsumoto

4

1 reference

26 March 2018

Hiroshi Okumura

5

1 reference

26 March 2018

Yasuto Uchikado

6

1 reference

26 March 2018

Yoshiaki Kita

7

1 reference

26 March 2018

Yuka Nishizono

8

1 reference

26 March 2018

Kosei Maemura

9

1 reference

26 March 2018

Yuko Kijima

10

1 reference

26 March 2018

Akihiro Nakajo

11

1 reference

26 March 2018

Tetsuhiro Owaki

12

1 reference

26 March 2018

Shinichi Ueno

13

1 reference

26 March 2018

Shuichi Hokita

14

1 reference

26 March 2018

Shoji Natsugoe

15

1 reference

26 March 2018

publication date

29 February 2012

1 reference

26 March 2018

Cancer Immunology, Immunotherapy

published in

1 reference

26 March 2018

volume

61

1 reference

26 March 2018

issue

10

1 reference

26 March 2018

page(s)

1663-1669

1 reference

26 March 2018

https://scigraph.springernature.com/pub.10.1007/s00262-012-1225-5

exact match

0 references

cites work

Gastric cancer surgery: an American perspective on the current options and standards

1 reference

https://api.crossref.org/works/10.1007%2FS00262-012-1225-5

Lymph node dissection in the resection of gastric cancer: review of existing evidence

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-012-1225-5

Surgical treatment of early gastric cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-012-1225-5

Clinicopathological study of cardiac tamponade due to pericardial metastasis originating from gastric cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-012-1225-5

Tumour escape mechanisms and their therapeutic implications in combination tumour therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-012-1225-5

Regulating the immune response to tumours

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-012-1225-5

Regulatory T cells and innate immune regulation in tumor immunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-012-1225-5

FoxP3: a genetic link between immunodeficiency and autoimmune diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-012-1225-5

Specific recruitment of regulatory T cells in ovarian carcinoma fosters immune privilege and predicts reduced survival

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-012-1225-5

Intratumoral balance of regulatory and cytotoxic T cells is associated with prognosis of hepatocellular carcinoma after resection.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-012-1225-5

Prevalence of FOXP3+ regulatory T cells increases during the progression of pancreatic ductal adenocarcinoma and its premalignant lesions.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-012-1225-5

Clinical implication of HLA class I expression in breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-012-1225-5

Japanese Classification of Gastric Carcinoma - 2nd English Edition -

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-012-1225-5

Type, density, and location of immune cells within human colorectal tumors predict clinical outcome

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-012-1225-5

Novel insights into the molecular mechanisms of HLA class I abnormalities

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-012-1225-5

Downregulation of HLA Class I molecules in the tumour is associated with a poor prognosis in patients with oesophageal squamous cell carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-012-1225-5

Enhanced functionality of CD4+CD25(high)FoxP3+ regulatory T cells in the peripheral blood of patients with prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-012-1225-5

Leukocyte infiltration and tumor cell plasticity are parameters of aggressiveness in primary cutaneous melanoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-012-1225-5

Depletion of regulatory T cells by anti-GITR mAb as a novel mechanism for cancer immunotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-012-1225-5

Agonist anti-GITR monoclonal antibody induces melanoma tumor immunity in mice by altering regulatory T cell stability and intra-tumor accumulation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-012-1225-5

Human leukocyte antigen (HLA) class I defects in head and neck cancer: molecular mechanisms and clinical significance

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-012-1225-5

Patients with oral squamous cell carcinoma are characterized by increased frequency of suppressive regulatory T cells in the blood and tumor microenvironment

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-012-1225-5

10.1007/S00262-012-1225-5

21 January 2018

Identifiers

DOI

1 reference

26 March 2018

PubMed ID

22374482

1 reference

26 March 2018